A 47-year-old non-alcoholic African-American woman was diagnosed to have multiple myeloma in December 1995. She received several cycles of chemotherapy with melphalan and prednisone. Initial days of chemotherapy were punctuated by recurrent hospital admissions for vomiting and abdominal discomfort, presumably due to chemotherapy. Serum amylase and lipase levels remained within normal limits during these admissions. Eighteen months after the initial diagnosis, she developed shortness of breath and left-sided chest pain. Serum lipase and amylase levels were normal. Computed tomography (CT) of the chest revealed a left intrathoracic pleural mass and bilateral effusions. Palliative radiotherapy was given to the left hemithorax, in addition to another cycle of chemotherapy.
Answers QUESTION 1 Acute pancreatitis should be the first consideration in such a patient, as acute pancreatitis secondary to hypercalcaemia is known to complicate the course of multiple myeloma.' However, in our patient, none of the imaging studies showed any evidence of pancreatitis. Although a normal CT scan need not necessarily rule out acute pancreatitis, two other considerations are important: * Macroamylasaemia. In a healthy individual, the serum amylase is the net balance between amylase production from the pancreas (P-isoamylase: 40%) and salivary gland (S-isoamylase 60%) and clearance by kidneys or reticuloendothelial system. Serum amylase can, rarely, be normal in acute pancreatitis (if there is massive pancreatic necrosis, delay in estimating serum amylase after the onset of symptoms, or if acute pancreatitis is secondary to hypertriglyceridaemia) 2 Elevated serum amylase level is due to leakage of amylase from the bowel lumen into serum and the levels are rarely more than three times normal 3 10% of chronic alcoholics have elevated salivary amylase; these individuals are at risk of acute as well chronic pancreatitis 4 Renal failure results in elevation of both P-and S-amylase. Serum lipase can also be elevated in renal failure (the elevations in amylase and lipase are seldom more than three times normal) QUESTION 2 Urine amylase and isoamylase estimation, with either electrophoresis or chromatography, would be useful. Elevated urine amylase in a patient with hyperamylsaemia effectively rules out macroamylasaemia and suggests a P-or S-isoamylase elevation. Likewise, a normal to low urine amylase in a patient with elevated serum amylase is indicative of macroamylasaemia, though rarely some salivary-type amylase can be cleared slowly, resulting a low urinary clearance similar to macroamylase. Apart from diagnosing macroamylasaemia, estimation of urine amylase or amylase creatinine clearance has no other clinical use. Twenty-four hour urine amylase in our patient was 17 400 IU/l which excluded the possibility of macroamylasaemia as the cause of elevated serum amylase.
Isoenzyme estimation can determine the type of amylase (S or P) that is elevated. Electrophoresis can also detect macroamylase. In the patient described here the serum amylase was almost entirely composed of S-amylase (98%) with a low P-isoenzyme. There was no macroamylase. It is most likely that the source of elevated amylase in our patient was ectopic production of S-amylase from the myeloma cells. It is interesting that, despite the presence of metastatic tumour, this patient did not have hyperamylasaemia on previous admissions. It is possible that the radiotherapy to the thoracic wall may have triggered the structural alteration in the tumour cells leading to salivary amylase production.6 The causes of elevated isoamylases are highlighted in the table. QUESTION 3 The probable cause of elevated serum lipase in this patient is macrolipase. For all practical purposes, the pancreas is the only source of serum lipase and hence elevated serum lipase is considered to be a more specific marker for pancreatitis (gastric lipase contributes minimally to serum lipase). Elevated serum lipase in the absence of pancreatitis is seen in renal insufficiency and in surgical conditions of the abdomen, such as bowel obstruction and perforation, and ischaemia. However, there are two welldocumented reports of elevated serum lipase in patients with high immunoglobulins as a result of immunoglobulin-lipase complex formation. 7 8 Lipase levels in one of these patients returned to normal after correction of hyperimmunoglobulinaemia. It is likely that hyperlipasaemia in our patient was due to macrolipase formation, although we did not confirm it by chromatography. Our patient had a downhill course and developed fulminant sepsis and multi-organ failure and died within 2 years of diagnosis of multiple myeloma.
Final diagnosis
Macroamylasaemia, due to ectopic production of S-amylase from myeloma cells, and hyperlipasaemia, due to macrolipase formation, in a patient with multiple myeloma.
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